RESUMEN
Biological approaches for the removal of heavy metals and radionuclides from contaminated water are reported. The present study was carried out with the objective of identifying bacterial strains for the uptake of cesium that could be used for bioremediation. Polymer carriers prepared by radiation polymerization were used for the immobilization of bacteria and the efficiency of free cells and immobilized cells for the removal of cesium was evaluated. Thirty-five bacterial isolates were screened for resistance to cesium and five bacterial isolates based on resistance to cesium (BR-3, BR-6, BR-21, BR-39, BR-40) were selected for immobilization. Polymer carriers were prepared using 10, 20, 30, 40 and 50% acrylamide at different doses of 1 to 5 kGy gamma radiation. The polymer carriers prepared using 30% and 40% acrylamide at 5 kGy were found to be suitable based on gel fraction and absorption capacity for the immobilization of bacterial cells. Bioremoval of cesium by free and immobilized bacterial cells was evaluated. Significant reductions of 76-81% cesium were observed with bacterial cells immobilized by radiation polymerization.
Asunto(s)
Bacterias/efectos de la radiación , Cesio , Biodegradación Ambiental , Células Inmovilizadas , PolimerizacionRESUMEN
Chitin and chitosan are biopolymers with excellent bioactive properties, such as biodegradability, non-toxicity, biocompatibility, haemostatic activity and antimicrobial activity. A wide variety of biomedical applications for chitin and chitin derivatives have been reported, including wound-healing applications. They are reported to promote rapid dermal regeneration and accelerate wound healing. A number of dressing materials based on chitin and chitosan have been developed for the treatment of wounds. Chitin and chitosan with beneficial intrinsic properties and high potential for wound healing are attractive biopolymers for wound management. This review presents an overview of properties, biomedical applications and the role of these biopolymers in wound care.
Asunto(s)
Vendas Hidrocoloidales , Biopolímeros/uso terapéutico , Quitina/uso terapéutico , Quitosano/uso terapéutico , Cicatrización de Heridas/efectos de los fármacos , Cicatrización de Heridas/fisiología , Heridas y Lesiones/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Picrorhiza kurroa is an important medicinal herb valued for iridoid glycosides, Picroside-I (P-I) and Picroside-II (P-II), which have several pharmacological activities. Genetic interventions for developing a picroside production platform would require knowledge on biosynthetic pathway and key control points, which does not exist as of today. The current study reports that geranyl pyrophosphate (GPP) moiety is mainly contributed by the non-mevalonate (MEP) route, which is further modified to P-I and P-II through phenylpropanoid and iridoid pathways, in total consisting of 41 and 35 enzymatic steps, respectively. The role of the MEP pathway was ascertained through enzyme inhibitors fosmidomycin and mevinolin along with importance of other integrating pathways using glyphosate, aminooxy acetic acid (AOA) and actinomycin D, which overall resulted in 17%-92% inhibition of P-I accumulation. Retrieval of gene sequences for enzymatic steps from NGS transcriptomes and their expression analysis vis-à-vis picrosides content in different tissues/organs showed elevated transcripts for twenty genes, which were further shortlisted to seven key genes, ISPD, DXPS, ISPE, PMK, 2HFD, EPSPS and SK, on the basis of expression analysis between high versus low picrosides content strains of P. kurroa so as to eliminate tissue type/ developmental variations in picrosides contents. The higher expression of the majority of the MEP pathway genes (ISPD, DXPS and ISPE), coupled with higher inhibition of DXPR enzyme by fosmidomycin, suggested that the MEP route contributed to the biosynthesis of P-I in P. kurroa. The outcome of the study is expected to be useful in designing a suitable genetic intervention strategy towards enhanced production of picrosides. Possible key genes contributing to picroside biosynthesis have been identified with potential implications in molecular breeding and metabolic engineering of P. kurroa.
Asunto(s)
Cinamatos/metabolismo , Inhibidores Enzimáticos/farmacología , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Glucósidos Iridoides/metabolismo , Picrorhiza/genética , Transcriptoma/genética , Vías Biosintéticas/efectos de los fármacos , Vías Biosintéticas/genética , Dactinomicina/farmacología , Perfilación de la Expresión Génica , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Genes de Plantas , Picrorhiza/efectos de los fármacos , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismoRESUMEN
Picrorhiza kurroa, has become an endangered medicinal herb due to excessive utilization, therefore it necessitates the understanding of biology and molecular basis of major chemical constituents i.e. Picroside-I (P-I) and Picroside-II (P-II). Estimation of P-I and P-II in different tissues of P. kurroa showed that shoots contain only P-I whereas P-II is present only in roots. Differential conditions with varying concentrations of P-I (0-27 µg/mg) and P-II (0-4 µg/mg) were selected. Four genes of MEP pathway; DXPS, ISPD, ISPE, MECPS and one gene of MVA pathway PMK showed elevated levels of transcripts in shoots (57-166 folds) and stolons (5-15 folds) with P-I contents 0-27 µg/mg and 2.9-19.7 µg/mg, respectively. Further HDS and DXPR genes of MEP pathway showed higher expression ~9-12 folds in roots having P-II (0-4 µg/mg). The expression of ISPH and ISPE was also high ~5 folds in roots accumulating P-II. GDPS was the only gene with high transcript level in roots (9 folds) and shoots (20 folds). Differential biosynthesis and accumulation of picrosides would assist in regulating quality of plant material for herbal drug formulations.
Asunto(s)
Genes de Plantas , Ácido Mevalónico/metabolismo , Picrorhiza/genética , Proteínas de Plantas/genética , Vías Biosintéticas , Cinamatos/metabolismo , Clonación Molecular , Especies en Peligro de Extinción , Regulación Enzimológica de la Expresión Génica , Regulación de la Expresión Génica de las Plantas , Glucósidos Iridoides/metabolismo , Especificidad de Órganos , Fosfotransferasas/genética , Fosfotransferasas/metabolismo , Picrorhiza/enzimología , Picrorhiza/metabolismo , Proteínas de Plantas/metabolismo , Raíces de Plantas/enzimología , Raíces de Plantas/genética , Raíces de Plantas/metabolismo , Brotes de la Planta/enzimología , Brotes de la Planta/genética , Brotes de la Planta/metabolismo , Plantas Medicinales/genética , Transcriptoma , Transferasas/genética , Transferasas/metabolismoRESUMEN
Chlorophenols are a class of chemicals commonly used in preservatives, disinfectants, algaecides, herbicides and pesticides. However, there is a growing evidence that these compounds are a threat to human health. This is alarming as many chlorophenols are common pollutants found in the global environment at potentially biohazardous levels. Despite chlorophenols being abundant, widely used and poisonous, we know relatively little about their mechanism of toxicity in eukaryotes. Thus, we performed genome-wide growth screens using Saccharomyces cerevisiae to understand the molecular basis of chlorophenol toxicity. Of â¼4850 single gene knockout strains tested, 393 mutants showed growth sensitivity to treatment with 4-chlorophenol (4-CP), 2,4-dichlorophenol (2,4-DCP) or pentachlorophenol (PCP). Only eight mutants showed growth hypersensitivity to all the three treatments and harboured deletions in genes important for aromatic amino acid biosynthesis (ARO1, ARO7) or mitochondrial protein synthesis and respiration (ATP5, ISA1, RML2, GET2, SLS1, MRPL38).